Results 11 to 20 of about 508,637 (297)

Natural organic matter coagulation [PDF]

open access: yes, 2005
The removal of natural organic matter (NOM) is one of the main challenges facing water utilities in both the UK and the US. As a consequence of changes in land management and an increased carbon loss from solids, a greater amount of accumulated ...
Sharp, Emma
core   +7 more sources

Global strict solutions to continuous coagulation–fragmentation equations with strong fragmentation [PDF]

open access: yes, 2011
In this paper we give an elementary proof of the unique, global-in-time solvability of the coagulation-(multiple) fragmentation equation with polynomially bounded fragmentation and particle production rates and a bounded coagulation rate.
Banasiak, Jacek   +3 more
core   +4 more sources

Recombinant factor IX‐Fc fusion protein in severe hemophilia B: Patient‐reported outcomes and health‐related quality of life

open access: yesResearch and Practice in Thrombosis and Haemostasis, 2021
Introduction In 2017, all people with severe hemophilia B in Ireland switched to recombinant factor IX Fc fusion protein concentrate (rFIXFc) prophylaxis.
Mairead O’Donovan   +11 more
doaj   +1 more source

Utility of ACMG classification to support interpretation of molecular genetic test results in patients with factor VII deficiency

open access: yesFrontiers in Medicine, 2023
BackgroundThe American College of Medical Genetics and Genomics (ACMG) and the Association for Molecular Pathology (AMP) have introduced an internationally shared framework for variant classification in genetic disorders.
Rosa Sonja Alesci   +4 more
doaj   +1 more source

Coagulation and fragmentation processes with evolving size and shape profiles : a semigroup approach [PDF]

open access: yes, 2013
We investigate a class of bivariate coagulation-fragmentation equations. These equations describe the evolution of a system of particles that are characterised not only by a discrete size variable but also by a shape variable which can be either discrete
Smith, Ann Louise   +2 more
core   +4 more sources

Higher cyclosporine-A concentration increases the risk of relapse in AML following allogeneic stem cell transplantation from unrelated donors using anti-thymocyte globulin

open access: yesScientific Reports, 2023
Cyclosporine-A (CsA) is used to prevent acute graft-versus-host disease (aGvHD). European Society for Blood and Marrow transplantation (EBMT) recommends a CsA target serum concentration of 200–300 µg/L during the first month after allogeneic ...
Mikael Lisak   +9 more
doaj   +1 more source

Direct Oral Anticoagulant removal by a DOAC filter: Impact on lupus anticoagulant testing – Evaluation on spiked and patient samples

open access: yesResearch and Practice in Thrombosis and Haemostasis, 2022
Background DOAC Filter (DF) is a new device to overcome interference in lupus anticoagulant (LAC) testing by direct oral anticoagulants (DOACs). Objectives We evaluated DOAC removal from plasma and elimination of DOAC interference in LAC testing by DF ...
Eleni A. Linskens   +2 more
doaj   +1 more source

Coagulation and non‐coagulation effects of thrombin [PDF]

open access: yesJournal of Thrombosis and Haemostasis, 2016
Thrombin is a multifunctional serine protease produced from prothrombin, and is a key regulator in hemostatic and non-hemostatic processes. It is the main effector protease in primary hemostasis by activating platelets, and plays a key role in secondary hemostasis.
Posma, J. J. N.   +2 more
openaire   +2 more sources

Heparin-induced thrombocytopenia and COVID-19

open access: yesHematology Reports, 2021
Heparin-induced thrombocytopenia (HIT) has not been included as a possible cause of thrombocytopenia in Coronavirus Disease 2019 (COVID-19) patients. We report a case of HIT in a patient with COVID-19 treated with heparin.
Michelangelo Sartori, Benilde Cosmi
doaj   +1 more source

Application of the thrombin generation assay in patients with antiphospholipid syndrome: A systematic review of the literature

open access: yesFrontiers in Cardiovascular Medicine, 2023
BackgroundThe antiphospholipid syndrome (APS) is classified by the presence of antiphospholipid antibodies (aPL) and thrombotic and/or adverse obstetric outcomes. The diagnosis and risk assessment of APS is challenging.
Rachel Gehlen   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy